Global Pharmaceuticals & Biotech High Insider Buying

Novo Nordisk

Market Cap: DKK 1.4t

Engages in the research and development, manufacture, and distribution of pharmaceutical products.

Pfizer

Market Cap: US$154.2b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

CSL

Market Cap: AU$66.3b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

Haleon

Market Cap: UK£32.2b

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

Zoetis

Market Cap: US$30.9b

Engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.

Ascendis Pharma

Market Cap: US$16.9b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.

CSPC Pharmaceutical Group

Market Cap: HK$99.2b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

Akeso

Market Cap: HK$94.0b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

Summit Therapeutics

Market Cap: US$11.9b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

Pharmaron Beijing

Market Cap: CN¥79.7b

Operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally.

Elanco Animal Health

Market Cap: US$11.1b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Ionis Pharmaceuticals

Market Cap: US$9.5b

A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.

Caris Life Sciences

Market Cap: US$6.6b

An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.

3SBio

Market Cap: HK$43.9b

An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.

Dyne Therapeutics

Market Cap: US$4.9b

A clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States.

Telix Pharmaceuticals

Market Cap: AU$5.7b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.

Aspen Pharmacare Holdings

Market Cap: R65.2b

Manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia.

AbCellera Biologics

Market Cap: US$2.9b

Engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.

Sunshine Lake Pharma

Market Cap: HK$21.2b

Engages in the research, development, manufacture, and sale of pharmaceutical products for the treatment of infectious diseases, chronic diseases, and oncology.

Nuvation Bio

Market Cap: US$2.3b

A clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment.

Duality Biotherapeutics

Market Cap: HK$17.6b

A clinical-stage biopharmaceutical company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others in China and internationally.

ADMA Biologics

Market Cap: US$2.2b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Genus

Market Cap: UK£1.5b

Produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia.

Kalbe Farma

Market Cap: Rp36.2t

Engages in the development, manufacture, and trading of pharmaceutical products in Indonesia.

Zenas BioPharma

Market Cap: US$2.0b

A clinical-stage biopharma company, engages in the development and commercialization of transformative immunology-based therapies.

Fujian Haixi Pharmaceuticals

Market Cap: HK$15.5b

Engages in research and development, production, and sale of pharmaceutical products in China.

Braveheart Bio

Market Cap: US$1.8b

A clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases.

Nanjing Leads Biolabs

Market Cap: HK$13.2b

A clinical-stage biotechnology company, engages in the research, development, and commercialization of novel antibody drugs worldwide.

Bonesupport Holding

Market Cap: SEK 14.8b

An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.

Absci

Market Cap: US$1.5b

A clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States.

Harrow

Market Cap: US$1.5b

An eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States.

Azenta

Market Cap: US$1.5b

Provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.

Phibro Animal Health

Market Cap: US$1.4b

Operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific.

Everest Medicines

Market Cap: HK$10.0b

A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.

Seaport Therapeutics

Market Cap: US$1.2b

A clinical-stage therapeutics company, focuses on inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders.

CStone Pharmaceuticals

Market Cap: HK$9.3b

A biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally.